Zobrazeno 1 - 10
of 267
pro vyhledávání: '"Amy D Shapiro"'
Autor:
Nihal Bakeer, Amy D Shapiro
Publikováno v:
F1000Research, Vol 8 (2019)
Bleeding with resultant hemophilic arthropathy constitutes the largest cause of morbidity in patients with hemophilia. It results from repeated bleeding episodes in the joint and is characterized by synovial hypertrophy and cartilage and bony destruc
Externí odkaz:
https://doaj.org/article/7540a3e5f2a946ea9be77f91ca50de09
Autor:
Amy D Shapiro
Publikováno v:
Vascular Health and Risk Management, Vol Volume 3, Pp 555-565 (2007)
Amy D ShapiroIndiana Hemophilia and Thrombosis Center, Indianapolis, IN, USAAbstract: Removal of blood-based additives from recombinant clotting factor concentrates continues to be advocated by the hemophilia community due to the history of infectiou
Externí odkaz:
https://doaj.org/article/8eaadd2f688a4082bcb50a05a24781af
Autor:
Charles Nakar, Heather McDaniel, Joseph M. Parker, Karen Thibaudeau, Neelam Thukral, Amy D. Shapiro
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
Plasminogen deficiency type 1 (PLGD-1, hypoplasminogenemia) is an ultra-rare, lifelong disease associated with development of fibrinous lesions in multiple organ systems. Depending on lesion location, clinical manifestations of PLGD-1 can result in a
Externí odkaz:
https://doaj.org/article/34a8a62f1f7c4028be26d8ed79ae06e3
Autor:
Diane Nugent, Suchitra S. Acharya, Kimberly J. Baumann, Camille Bedrosian, Rebecca Bialas, Kai Brown, Deya Corzo, Amar Haidar, Catherine P. M. Hayward, Peter Marks, Marzia Menegatti, Margaret E. Miller, Kate Nammacher, Roberta Palla, Skye Peltier, Rajiv K. Pruthi, Michael Recht, Benny Sørensen, Michael Tarantino, Alisa S. Wolberg, Amy D. Shapiro
Publikováno v:
Expert Review of Hematology. 16:55-70
Autor:
Amy D. Shapiro, Marzia Menegatti, Roberta Palla, Marco Boscarino, Christopher Roberson, Paolo Lanzi, Joel Bowen, Charles Nakar, Isaac A. Janson, Flora Peyvandi
Publikováno v:
Haematologica, Vol 105, Iss 3 (2020)
Plasminogen deficiency is an ultra-rare multisystem disorder characterized by the development of fibrin-rich pseudomembranes on mucous membranes. Ligneous conjunctivitis, which can result in vision impairment or loss, is the most frequent symptom rep
Externí odkaz:
https://doaj.org/article/8302c43f660645b99648d0e1b22824c7
Autor:
Suman L. Sood, Dunlei Cheng, Margaret Ragni, Craig M. Kessler, Doris Quon, Amy D. Shapiro, Nigel S. Key, Marilyn J. Manco-Johnson, Adam Cuker, Christine Kempton, Tzu-Fei Wang, M. Elaine Eyster, Philip Kuriakose, Annette von Drygalski, Joan Cox Gill, Allison Wheeler, Peter Kouides, Miguel A. Escobar, Cindy Leissinger, Sarah Galdzicka, Marshall Corson, Crystal Watson, Barbara A. Konkle
Publikováno v:
Blood Advances, Vol 2, Iss 11, Pp 1325-1333 (2018)
Abstract: Men with hemophilia were initially thought to be protected from cardiovascular disease (CVD), but it is now clear that atherothrombotic events occur. The primary objective of the CVD in Hemophilia study was to determine the prevalence of CV
Externí odkaz:
https://doaj.org/article/99884cf58b7146a988277d3156b87753
Publikováno v:
Haemophilia. 29:928-930
Gastrointestinal (GI) tract bleeding can present as symptomatic anemia in children. This presentation warrants evaluation for GI tract pathology and consideration of coagulation assays to rule out an underlying bleeding diathesis. A male child was di
Autor:
Amy D. Shapiro, Aby Abraham, Silvia Linari, Jesper Skov Neergaard, Jan Odgaard-Jensen, Jay Jay Thaung Zaw, Huyen Tran
Publikováno v:
Blood. 140:2732-2734
Autor:
Omotola O, Olasupo, Craig, Haddix, Charles, Nakar, Jennifer, Maahs, Anne, Greist, Azam, Ghafoor, Sharyne M, Donfield, Alfonso, Iorio, Amy D, Shapiro
Publikováno v:
European Journal of Haematology. 108:232-243
To describe the Indiana Hemophilia and Thrombosis Center (IHTC) surgical database, its key components, and exploratory analyses of surgeries conducted between 1998 and 2019.Surgical data across bleeding disorders collected retrospectively (1998-2006)
Autor:
Amy D. Shapiro, Roshni Daniel Kulkarni, Margaret V Ragni, Herve Chambost, Johnny N Mahlangu, Johannes Oldenburg, Beatrice Nolan, Margareth C Ozelo, Meredith C Foster, Annemieke Willemze, Chris Barnowski, Nisha Jain, Bent Winding, Jennifer Dumont, Stefan Lethagen, Chris Barnes, K John Pasi
Publikováno v:
Blood Advances.
Long-term efficacy and safety of the extended half-life recombinant FIX Fc fusion protein (rFIXFc) has been established in previously treated patients with severe hemophilia B in 2 Phase 3 trials (B-LONG [NCT01027364] and Kids B-LONG [NCT01440946]) a